felin
infecti
periton
fip
immunemedi
diseas
domest
exot
felid
infect
felin
coronaviru
fip
character
overexpress
acut
phase
protein
glycoprotein
agp
human
agp
heavili
glycosyl
protein
undergo
sever
modif
glycan
moieti
acut
chronic
inflammatori
patholog
studi
chang
agp
glycosyl
cours
fip
specif
focuss
attent
degre
sialyl
fucosyl
branch
studi
present
purif
method
felin
agp
fagp
serum
use
ion
exchang
chromatographi
strategi
glycosyl
pattern
analyz
detail
mean
interact
purifi
fagp
specif
lectin
particular
sambucu
nigra
agglutinin
maackia
amurensi
agglutinin
lectin
use
detect
sialic
acid
residu
aleuria
aurantia
lectin
use
detect
lfucos
residu
concanavalin
use
evalu
branch
degre
method
show
fagp
present
lfucos
residu
surfac
branch
degre
low
normal
patholog
condit
contrast
fip
diseas
fagp
underw
sever
modif
sialic
acid
content
includ
decreas
express
link
link
sialic
acid
respect
compar
nonpatholog
felin
agp
decreas
sialyl
acut
phase
protein
glycoprotein
felin
infecti
periton
fip
felin
infecti
periton
fip
immunomedi
diseas
domest
exot
felid
infect
felin
coronaviru
fcov
pedersen
fip
develop
cat
expos
variant
fcov
replic
within
macrophag
therebi
spread
viru
target
organ
pathogenesi
fip
complex
still
well
understood
two
posit
acut
phase
protein
glycoprotein
agp
haptoglobin
hp
report
increas
fip
duthi
et
al
hp
concentr
fip
approxim
twice
maximum
valu
healthi
cat
interest
howev
level
agp
increas
gl
biolog
signific
agp
overexpress
fip
correl
veterinari
immunolog
immunopatholog
abbrevi
fip
felin
infecti
periton
agp
glycoprotein
fagp
felin
glycoprotein
fcov
felin
coronaviru
hp
haptoglobin
slex
sialyl
lewi
x
hplc
high
pressur
liquid
chromatographi
snai
sambucu
nigra
agglutinin
maa
maackia
amurensi
agglutinin
aal
aleuria
aurantia
lectin
correspond
author
tel
fax
email
address
fabrizioceciliani
unimiit
f
ceciliani
pathogenesi
diseas
still
unknown
agp
glycoprotein
molecular
weight
rang
kda
depend
speci
one
interest
characterist
agp
extent
carbohydr
moieti
account
approxim
molecular
weight
fournier
et
al
glycan
nlink
form
five
six
speci
complextyp
could
theoret
increas
differ
glycoform
far
glycoform
agp
detect
nonpatholog
human
serum
human
agp
overexpress
system
inflammatori
respons
cours
sever
patholog
hochepi
et
al
precis
function
unknown
data
report
far
would
suggest
immunomodulatori
activ
specif
agp
inhibit
neutrophil
chemotaxi
activ
vasson
et
al
may
respons
increas
receptor
antagonist
secret
tilg
et
al
vivo
experi
suggest
agp
may
involv
induct
nonspecif
resist
infect
exampl
block
bind
hiv
chemokin
receptor
human
macrophag
atemezem
et
al
oligosaccharid
microheterogen
agp
profoundli
affect
patholog
condit
differ
glycoform
appear
plasma
system
inflamm
diseas
de
graaf
et
al
van
dijk
et
al
alter
glycan
moieti
believ
import
sever
agp
immunomodulatori
activ
exampl
reduct
degre
branch
attach
oligosaccharid
correl
reduct
activ
bori
et
al
chang
amount
fucos
residu
found
increas
human
inflammatori
diseas
fucosyl
agp
express
sialyl
lewi
x
slex
epitop
could
counteract
extravas
leukocyt
slex
ligand
endotheli
selectin
brinkmanvan
der
linden
et
al
de
graaf
et
al
final
sever
defens
function
propos
agp
associ
sialic
acid
content
sialic
acid
import
compon
membran
glycoprotein
agp
may
therefor
act
competitor
cell
surfac
receptor
block
bind
invas
infecti
agent
friedman
hochepi
et
al
therefor
agp
carbohydr
moieti
modif
may
repres
import
mechan
strategi
inflammatori
respons
high
level
agp
describ
cat
serum
fip
duthi
et
al
due
import
glycan
moieti
immunomodulatori
activ
agp
target
attent
posttransl
process
protein
fip
infect
present
studi
use
lectin
bind
specif
carbohydr
order
gain
insight
major
branch
minor
sialic
acid
content
glycan
microheterogen
felin
agp
fagp
purifi
fip
affect
cat
particular
aim
studi
setup
protocol
purif
fagp
cat
serum
b
evalu
normal
patholog
express
surfac
fagp
sialic
acid
fucos
c
evalu
possibl
chang
degre
branch
oligosaccharid
chain
serum
sampl
ml
obtain
clinic
healthi
cat
male
femal
use
control
fagp
purif
determin
nonpatholog
glycosyl
pattern
fagp
sinc
analysi
glycosyl
pattern
individu
nonpatholog
fagp
sampl
reveal
differ
fagp
healthi
cat
pool
use
throughout
experi
control
sampl
collect
cat
affect
fip
male
femal
diagnos
follow
post
mortem
examin
immunohistochem
detect
fcov
within
lesion
fcovexpos
cat
male
femal
ie
cat
cohabit
fip
affect
cat
develop
diseas
cat
use
experi
neg
felin
immunodefici
viru
felin
leukemia
viru
fagp
isol
convent
hplc
ion
exchang
chromatographi
avoid
desialyl
structur
degrad
cat
serum
ml
sampl
dialyz
overnight
buffer
use
initi
chromatographi
mm
citratephosph
buffer
ph
serum
centrifug
g
min
remov
protein
solubl
ph
supernat
appli
hitrap
q
sepharos
strong
anion
exchang
column
amersham
bioscienc
equilibr
start
buffer
column
wash
start
buffer
absorb
record
nm
protein
elut
mm
citratephosph
buffer
ph
fraction
contain
fagp
approxim
ml
concentr
centricon
millipor
ml
directli
load
onto
hitrap
sp
sepharos
strong
cation
exchang
column
amersham
bioscienc
equilibr
mm
citratephosph
buffer
ph
condit
fagp
retain
column
therefor
elut
void
volum
purifi
fagp
mg
lane
subject
sdspage
discontinu
ph
system
laemmli
use
miniprotean
ii
apparatu
biorad
stack
gel
separ
gel
gel
stain
coomassi
blue
electroblot
onto
nitrocellulos
total
protein
visual
stain
gel
h
accord
biosaf
coomassi
method
biorad
western
blot
perform
mini
tran
blot
electrophoresi
cell
biorad
onto
nitrocellulos
fagp
detect
antifagp
polyclon
antibodi
rais
sheep
gener
provid
dr
duthi
univers
glasgow
alkalin
phosphataseconjug
goat
antisheep
secondari
antibodi
blot
develop
use
amplifi
ap
immunblot
kit
biorad
four
lectin
use
studi
digoxigeninconjug
lectin
sambucu
nigra
agglutinin
snai
roch
maackia
amurensi
agglutinin
maa
roch
bind
sialic
acid
residu
specif
linkag
snai
specif
sialic
acid
link
galactos
maa
recogn
sialic
acid
link
galactos
two
lectin
use
concentr
mgml
respect
biotinconjug
lectin
aleuria
aurantia
aal
vector
laboratori
show
affin
link
fucos
concanavalin
vector
laboratori
bind
diantennari
glycan
lower
affin
triand
tetraantennari
glycan
two
lectin
also
wide
util
evalu
presenc
fucosyl
slex
aal
degre
branch
cona
glycoprotein
surfac
lectin
use
concentr
mgml
aal
mgml
cona
glycan
analysi
fagp
react
digoxigeninconjug
lectin
perform
follow
glycan
differenti
kit
roch
accord
method
haselbeck
et
al
digoxigeninlabel
lectin
identifi
alkalin
phosphatas
conjug
sheep
antidigoxigenin
immunoglobulin
glycan
analysi
fagp
react
biotinconjug
lectin
perform
follow
peroxidas
reaction
use
vectastain
abc
kit
vector
laboratori
develop
use
hrp
immunblot
assay
kit
biorad
protein
content
determin
direct
spectophotometr
measur
nm
coomassi
blue
dye
bind
method
bradford
densitometr
analysi
perform
use
imagemast
softwar
amersham
bioscienc
membran
process
scanner
subject
computer
imag
analysi
membran
imag
profil
plot
obtain
display
fagp
peak
volum
peak
calcul
softwar
fig
report
chromatograph
procedur
set
purifi
fagp
fraction
contain
fagp
fig
fraction
qsepharos
chromatographi
load
onto
spsepharos
chromatographi
column
elut
fraction
fig
fraction
contain
purifi
fagp
puriti
determin
sdspage
fig
insert
lane
show
singl
band
gel
coomassi
blue
stain
identif
homogen
band
fagp
determin
western
blot
use
polyclon
antifagp
antibodi
primari
antibodi
fig
insert
wb
lane
fig
show
repres
glycosyl
pattern
nonpatholog
fagp
glycosyl
pattern
ident
among
control
cat
particular
degre
sialyl
determin
lectinbind
fagp
snai
sialic
acid
link
galactos
maa
sialic
acid
link
galactos
lane
respect
degre
fucosyl
aal
lane
degre
branch
cona
lane
fagp
strongli
react
snai
minor
affin
maa
reactiv
fagp
snai
maa
present
densiti
plot
fig
dendrogram
display
averag
volum
densiti
profil
plot
nonpatholog
fagp
reaction
snai
maa
shown
fig
figur
show
variabl
noninfect
cat
low
contrari
fagp
glycoform
healthi
cat
bind
lectin
aal
cona
nonreact
fagp
two
lectin
therefor
suggest
nonpatholog
condit
protein
present
fucos
residu
surfac
glycoform
one
diantennari
glycan
limit
fig
report
glycosyl
pattern
fagp
purifi
fip
affect
cat
lane
np
repres
pool
nonpatolog
fagp
patholog
fagp
fip
affect
cat
load
onto
lane
case
patholog
fagp
react
aal
fig
cona
fig
result
suggest
fagp
express
fip
present
fucos
residu
surfac
branch
degre
increas
diseas
fig
show
sever
differ
sialyl
fagp
among
fip
affect
cat
sever
protein
exampl
lane
share
evid
desialyl
quantifi
densitometri
respect
data
report
compar
control
contrari
protein
lane
exhibit
increas
degre
sialyl
respect
data
report
cat
lane
sialyl
fagp
modifi
fip
histogram
fig
present
semiquantit
evalu
peak
correspond
fagp
profil
shown
fig
use
lectin
snai
sialic
acid
link
content
fagp
fip
affect
cat
decreas
averag
compar
nonpatholog
fagp
therefor
conclud
sialyl
fagp
reduc
fip
contrari
reaction
maa
lectin
fig
preferenti
bind
link
sialic
acid
residu
show
mark
differ
bind
nonpatholog
patholog
fagp
except
one
fagp
lane
patholog
fagp
purifi
experi
clearli
show
mark
reduct
reaction
maa
lectin
decreas
strong
sever
cat
protein
exampl
lane
show
clear
desialyl
quantifi
densitometri
respect
data
report
compar
nonpatholog
fagp
result
strongli
support
hypothesi
mark
decreas
sialic
acid
residu
link
galactos
posit
use
lectin
maa
sialic
acid
link
content
patholog
fagp
decreas
averag
valu
compar
nonpatholog
fagp
fig
analysi
glycosyl
pattern
patholog
fagp
detect
oligosaccharid
chain
perform
western
blot
use
interact
snai
b
maa
c
aal
cona
np
mg
pool
nonpatholog
fagp
lane
mg
fagp
fip
affect
cat
fagp
stain
describ
section
arrow
right
indic
posit
fagp
examin
whether
differ
nonpatholog
fagp
fagp
fipexpos
cat
could
observ
data
shown
previou
experi
aal
cona
show
reaction
agp
contrari
snai
maa
exhibit
strong
reaction
fagp
howev
differ
nonpatholog
patholog
form
observ
fig
moreov
strong
similar
electrophoret
mobil
protein
data
present
may
suggest
fagp
fip
expos
cat
share
oligosaccharid
moieti
fagp
healthi
cat
report
plasma
acut
phase
protein
agp
concentr
increas
two
five
time
fip
duthi
et
al
studi
demonstr
sever
posttransl
modif
fagp
cours
fip
specif
glycan
moieti
analyz
bind
specif
lectin
evid
posttransl
modif
fip
decreas
degre
sialyl
function
fagp
clearli
defin
howev
report
data
suggest
antiinflammatori
immunomodulatori
role
heavi
glycosyl
level
agp
total
mw
strongli
suggest
involv
glycan
moieti
agp
function
fig
histogram
display
averag
volum
densiti
profil
plot
nonpatholog
fagp
compar
fip
affect
cat
fip
expos
cat
b
reaction
snai
maa
valu
express
rel
pixel
intens
fagp
glycosyl
pattern
fip
surprisingli
origin
compar
report
literatur
diseas
human
diseas
includ
rheumatoid
arthriti
hiv
serum
agp
exhibit
sever
featur
includ
increas
fucosyl
level
degre
branch
level
elliot
et
al
found
branch
degre
fucosyl
level
fagp
increas
fip
report
mice
fucos
epitop
expos
prolong
inflammatori
reaction
due
absenc
mous
liver
havenaar
et
al
possibl
cat
may
also
lack
enzym
furthermor
result
clearli
indic
fip
affect
cat
exhibit
mark
modif
sialic
acid
content
reduct
sialic
acid
link
galactos
particularli
mark
sever
subject
cat
number
epitop
sialic
acid
unchang
increas
therefor
may
conclud
desialyl
occur
individu
basi
like
correl
diseas
also
observ
strong
reduct
compar
control
sialic
acid
link
galactos
surfac
purifi
fagp
desialyl
occur
vari
degre
cat
fcov
expos
cat
appar
present
sialic
acid
lfucos
glycan
branch
modif
result
suggest
probabl
fip
simpl
infect
fcov
may
caus
major
glycan
modif
surfac
agp
present
data
avail
regard
biolog
differ
linkag
sialic
acid
galactos
due
neg
electr
charg
termin
local
sialic
acid
residu
play
import
role
mediat
intercellular
recognit
event
also
thought
sialyl
glycoprotein
exert
antiproteolyt
activ
de
facto
prolong
life
protein
desialyl
caus
molecul
recogn
galactos
specif
lectin
recognit
target
desialyl
serum
glycoprotein
hepatocyt
remov
circul
lamari
karamano
moreov
sialic
acid
compon
receptor
cytokin
selectin
siglec
sialic
acidbind
immunoglobulin
superfamili
lectin
trave
schauer
data
present
suffici
suggest
role
fagp
pathogenesi
fip
present
specul
physiolog
patholog
role
desialyl
immunomodulatori
function
agp
desialyl
agp
connect
reduct
halflif
agp
therefor
reduct
immunomodulatori
properti
agp
interact
monocyt
induc
increas
secret
receptor
antagonist
modul
lpsinduc
cytokin
express
fournier
et
al
modif
glycan
moieti
alter
bind
patholog
agp
monocyt
thu
increas
decreas
activ
capabl
cell
fip
develop
cat
expos
mutat
fcov
acquir
capabl
replic
macrophag
stoddart
scott
therefor
conceiv
interact
differ
agp
glycoform
may
elicit
differ
macrophag
reaction
conclus
report
studi
chang
glycosyl
fagp
occur
fip
sinc
inform
current
avail
concern
glycosyl
fagp
felin
patholog
inde
avail
human
mice
moment
imposs
propos
fagp
glycosyl
pattern
addit
specif
marker
diagnosi
patholog
howev
studi
carbohydr
moieti
fagp
diseas
state
evalu
whether
protein
overexpress
warrant
